Click Therapeutics Funding: $218M Raised, Series D (2025)
Click Therapeutics is based in New York City, NY. It has raised $218M in total funding. Latest round: Series D.
Click Therapeutics funding overview
Click Therapeutics is based in New York City, NY. Click Therapeutics has raised $218M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in March 2025. The round record for Click Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Sanofi Ventures, H.I.G. BioHealth Partners, Accelmed Partners II, Dassault Systèmes, Medidata, Boehringer Ingelheim. 6 distinct backers are named across the disclosed rounds.
Click Therapeutics has raised $218M in total disclosed funding across the rounds on record.
Who has invested in Click Therapeutics?
Sanofi Ventures, H.I.G. BioHealth Partners, Accelmed Partners II, Dassault Systèmes, Medidata, Boehringer Ingelheim are named among the investors backing Click Therapeutics.
What was the latest Click Therapeutics funding round?
The most recent disclosed round is a Series D, announced in March 2025.
Where is Click Therapeutics based?
Click Therapeutics is based in New York City, NY.
When did Click Therapeutics last raise?
The last disclosed Click Therapeutics round closed in March 2025 at Series D.
Totals shown for Click Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in New York City and the investors behind them below.
